SlideShare a Scribd company logo
1 of 50
CATH MEET
Dr.NAGULA PRAVEEN
Case
• 2 year old male child.
• h/o recurrent LRTIs at presentation.
• Patient had h/o breathing difficulty, feeding difficulty and poor
weight gain at the age of 3 months. Symptoms decreased with
medications,was diagnosed to have a heart disease at this
admission.
• No H/o cyanotic spells, pedal edema .
• No F/o consanguinity, no other member in the family having a
Heart disease.
On examination:
Physical Examination:
• weight-8kg, height-81 cm,
• No anemia,no cyanosis,no jaundice,no clubbing,no
lymphadenopathy,no pedal edema.
Vitals :
• Pulse - 106/min,regular,high volume & no special character
no Radio radial or radiofemoral delay.
• B.P-110/50mmhg,
• RR-25/min,
• Afebrile.
CardioVascular System
• JVP : normal mean column height with normal wave pattern.
Inspection & Palpation :
• Apex is in 6th ICS,LV type at Anterior Axillary line, hyperdynamic.
• Grade 2/3 parasternal pulsations felt,
• Palpable P2,
• Systolic thrill in 1st & 2nd Lt ICS.
Auscultation:
• S1-Normal
• S2- Narrow split ; P2 >A2 in Pulmonary Area
• no additional sounds
• A 4/6 long systolic murmur most prominent in 1st & 2ndLt ICS, high
pitched,increases with inspiration,
• no other murmur.
ECG
ECHO
• Situs solitus,levocardia, 2atria,2ventricles, AV –VA concordance ,
NRGA , normal systemic and pulmonary venous drainage.
• PDA of size 8mm - shunt is Left to right shunt with Pressure
Gradient of 25 mm hg in systole and 10mm in diastole.
• PA Systolic pressure of 80 mm hg.
• LA, LV are dilated .
• Mild MR,no PR,TR.
• Normal biventricular function
• No associated VSD,COA, ASD.
• Left sided aortic arch.
 2 year old,Height - 81 cm, weight - 8.5 kg, BMI- 12.95 Kg/m²,
 Hb-10.1gm/dl, O2 con-175 ml/min/mt², BSA- 0.48 m²
 Catheter course:
RT FV---IVC---RA--- RV--- PA---PCW
RT FA---Ao---LV PDA ---DES.AORTA.
CATHETERISATION
PRESSURE DATA in mm Hg
FA--- 110/50 (67)
RA--- 4
RV--- 80/0-6
PA--- 80/40(54)
PCWP--- 5
LV--- 106/0-8
SATURATION DATA in %
SVC--- 64.6
IVC--- 68.6
MVO2--- 65.07
RA--- 63.4
RV--- 67.5
PA--- 83.4
FA--- 94.9
PV - 98.0
• Qp = 175/13.6 × 10.1×(0.98 -0.83) = 8.73 L/min.
• Qs = 175/13.6 × 10.1 ×(0.95 -0.67) = 4.77 L/min.
• Qp/Qs = 8.73/4.77 = 1.83
• PVR = 54-5 / 8.73 = 5.612 wood units
• SVR = 67-4 / 4.77 = 13.2 wood units
• PVRI/SVRI = 5.612/13.2 = 0.425
CATHETERISATION
CATHETERISATION
POST O2
Pressure Data in mm Hg
FA--- 120/74 (90)
RA--- 3
RV--- 70/0-4
PA--- 70/40(50)
PCWP--- 15
LV--- 115/0-6
Saturation data in %
SVC--- 82.1
IVC--- 87.5
MVO2--- 83.45
PA--- 98.7 (pO2=161mmhg)
FA--- 99.9 (pO2 =417mmhg)
• Qp = 175/(13.6×10.1×0.99+13.34) – (13.6×10.1×0.987 + 5.15) =
17.78L/min.
• Qs = 175/(13.6 ×10.1×0.99+13.34)-(13.6×10.1×0.834+1.8) =
6.04L/min.
• Qp/Qs= 17.78/6.04 = 2.94
• PVR= 50-15/17.78 = 1.96 wood unit
• SVR= 90-3= 14.40 wood unit
• PVRI/SVRI =1.96/14.40 = 0.136
CATHETERISATION
POST O2
Case 2
• 3 yr old F
• Wt 13.6 kgs
• Child had been very active,without evident dyspnea or cyanosis.
• A murmur was first reported at 1 ½ yrs.
• Her development was normal for her age.
• Mild pallor
• JVP normal,BP – 104/38mmHg
• Systolic at left 2nd and 3rd Left ICS.
• P2 masked by murmurs.
• Very loud,continuous,machinery type systolic and diastolic
murmurs,left 2nd 3rd ICS.
• ECG- normal ,normal axis,LVH
Cath data
Pressure data (mm Hg)
• RA – 5
• RV – 31/4 (13)
• PA – 30/13(19)
• LA – 8
• LV – 90/40 (65)
Saturation data
• IVC – 65
• SVC – 62
• MV02 – 62.75
• RA – 61
• RV - 65
• MPA – 65
• LPA – 80
• AORTA – 95
PDA without pulmonary hypertension
Qs – 2.38 l/min
Qp – 4.98 l min
Qp/Qs – 2.09:1
Case3
• 8yrs old F
• Weight 18.4 kg
• 2 episodes of pneumonia and frequent bronchitis.
• Less active than other children.easy fatiguability and dyspnea on climbing more
than one flight of stairs.
• No h/o suggestive of rheumatic fever.
• Fragile,under developed child.
• No cyanosis.
• Examination: slight precordial bulge to left of sternum.
• JVP normal
• Systolic thrill at left 2nd ICS.
• S1 loud,P2 accentuated.
• Long loud coarse systolic
• Coarse early to mid diastolic left 2nd ICS.
• High pitch Systolic murmur LLSB.
• MDM at apex
• ECG- notching of P wave,biventricular hypertrophy
Cath data
• Saturation data:
• SVC – 60
• IVC – 65
• MVO2 – 61.25
• RA – 60
• RV – 72
• PA – 88
• PV - 98
• Aorta -98
Pressure data:
RA – 5
RV - 64/6(25)
PA – 64/23(39)
LV – 104/10
Aorta – 107/46(73)
LA – 8
Qp = 9.50 lit/min
Qs = 3.10 lit/min
L-R shunt ventricular – 0.90 lit/min
Aorta to pulmonary – 5.5 lit/min
PDA with VSD with pulmonary hypertension
PATENT DUCTUS ARTERIOSUS
Indications for catheterization
• Usually does not require.
• Color doppler is as sensitive as cardiac catheterization for
detecting even a small PDA.
• 1.Clinical findings – symptomatology discreprancy.
• 2.Severity of pulmonary hypertension.
• 3.Reactivity to pulmonary vasodilators.
• 4.If closure is indicated in a particular case scenario.
• 5.Detection of assosciated lesions.
• Right heart catheterization – suffices to confirm diagnosis.
• Venous catheter from MPA – PDA – descending aorta.
• Retrograde – if interatrial spetum is intact, LV cannot be
entered prograde.
• Catheters used.
• Multipurpose catheter
• Pigtail
Angiographic views
• Defining the anatomy of the PDA.
• Left Lateral projection. – for sizing of device
• LAO 60 - profile of PDA
• RAO caudal
• RAO 30 – ampulla at pulmonary end
Isolated PDA type A
DuctusinTricuspidatresia
Ductusarisingmoreproximally
Ductusarisingmoreproximally,elongated
Ductusarisingveryproximallyundersideofarchtypicallyseenin
TOF-PA
DuctusarisingfromsubclavianarteryinTOFPAwithrightsided
aorticarch
Significant shunt at great arteries
• An increase of pulmonary arterial blood oxygen content of
>0.5mL/dL or a saturation increase of >4% to 5% from that
in right ventricular blood indicates a significant left to right
shunt at the pulmonary arterial level.
Imp points
Feature Implication
Increase in O2 saturation just below the
pulmonary valve
Pulmonary Regurgiation
A sample from either one of the pulmonary
artery branches does not reflect mixed
pulmonary arterial blood oxygen saturation
preferential streaming of oxygenated blood
from the PDA into one or another
pulmonary branch.
Accurate pulmonary blood flow from blood
oxygen data
difficult
Accurate calculation of true magnitude of
left to right shunting
impossible
Reduced PVO2 LV failure with pulmonary edema
Increased O2 saturation in RA blood PFO with L-R shunt
Presence of large ASD Masks the significant shunt at great artery
level
O2 saturation of blood in the descending
aorta less than that obtained in the
ascending aorta
Significant Pulmonary hypertension,R-L
shunting
• Increase in oxygen saturation in pulmonary arterial blood is
not diagnostic of a PDA,
But may be present in lesions such as
• Aortopulmonary window,
• Supracristal VSD,
 streaming may direct the highly saturated blood into the pulmonary
artery.
• Calculation of pulmonary blood flow is inaccurate,the calculation
of pulmonary vascular resistance is also inaccurate.
Shunt depends upon
3 major factors
• Diameter and the length of the ductus arteriosus
• Pressures between the aorta and the pulmonary artery
• Systemic and pulmonary vascular resistances
Pulmonary arterial
blood pressure
Systemic arterial
pressures
Pulse pressure
SBP/DBP/MP SBP/DBP/MP
Small PDA normal Low diastolic pressure widened
Moderate sized PDA Slightly elevated,less
than Systemic
Pressures
Low DBP
Mean pressure elevated
widened
Large PDA with
pulmonary
hypertension
Equal to Systemic
pressures
Increased LVEDP
Diastolic gradient between
LA and LV
LA mean pressure may be
increased
Prominent V wave
Small systolic difference
between LV and aorta
decreased
Classifications
• Krichenko’s classification
• Sri Chitra Tirunal classification
• Size of the ductus
• Staging of PDA
Krichenko classification
Type A : CONICAL ductus
Well defined aortic ampulla
Constriction near pulmonary artery end
Type B : WINDOW ductus
Very short length
Type C : TUBULAR ductus
No constrictions
Type D: COMPLEX ductus
multiple constrictions
Type E: ELONGATED ductus
Constriction remote from the anterior edge of trachea
Krichenko et al .Am J Cardiol.1989;63:877-79
Sri Chitra Tirunal Classification of PDA,
ProfJaganMohanA.Tharakanetal.(2003)
• Angiographic appearance of PDA
• Retrograde analysis of the appearance of PDA on angiography
selected for device closure.
Magnification factor = catheter size measured on the screen
/ Actual catheter size.
• Measurement of anatomical components of ductus
Ex:
Ampulla size = ampulla measured on screen / magnification
factor.
Lateral view
167 pts
Patentductusarteriosus
Saucer shaped
Length of the ductus < 6 mm
Narrowing at PA end by > 50% of the
width of the ampulla
Cylindrical
(tubular ductus)
Length of ductus > 6mm
Narrowing at PA end by < 50 % the
width of ampulla
Conical
(cup shaped)
Length of ductus > 6mm
Narrowing at PA end >50% of the width of ampulla
Length of this narrow portion (stem of the ductus ) <
1/3 of the total length of the ductus
Funnel shaped
Similar to conical
Longer stem >1/3 of the total length
of ductus
Hour glass shaped Ampulla at both PA end and the
aortic end
Patent Ductus Arteriosus
Length of ductus
< 6mm
PA end narrowing
> 50% of width
of ampulla
Saucer
shaped
> 6mm
PA end narrowing
> 50% width of ampulla
Length of narrow
portion
< 1/3
of length of ductus
Conical
(cup shaped)
Longer
stem
Funnel shaped
< 50 % of
width of ampulla
Cylindrical
Ampulla
Usually at
aortic end
At both ends
Hourglass type
Saucer shaped ductus
Shallow depth of ductus
Hardly any narrowing at the pulmonary end
Based on size of ductus
Staging of PDA
• Clinical
• C1 – Asymptomatic
• C2 – Mild
• C3 – Moderate
• C4 – severe
• Echocardiography
• E1 – no evidence of flow on 2D or doppler interrogation
• E2 - small non significant ductus
• E3 – moderate HSDA
• E4 - Large HSDA
Staging of PDA
Treatment of preterm infantsMedical :
Oral /IV indomethacin
• Effects are apparent when administered < 10 days of age, less mature infants.
• Infants <1000g before manifestation (<72 hrs of age).
• C/I : Renal dysfunction, necrotizing enterocolitis,overt bleeding, shock, ECG
evidence of myocardial ischemia.
• Serum creatinine >1.6mg/dl, BUN >20 mg/dl.
• Dose – 0.2mg/kg NG or IV.
• A total of three doses,12-24 hrs apart, based on urinary output.
• If urine flow decreases – increase the time period or less doses.
• Second course if clinical signs reappear.
• True prophylactic therapy on the first day after birth - no advantage.
• Refractory patients – L NMMA and indomethacin.
Ibuprofen (less side effects,increased pulmonary hypertension).
Oral paracetamol
< 48 hrs Subsequent two doses are 0.10mg/kg IV
2-7 days 0.20mg/kg
>7 days 0.25mg/kg
Surgical
• Unsuccessful /not possible medical treatment.
• <10 days of age -  duration of ventilatory support,hospital
stay,lowers morbidity.
• Ligation rather than division of ductus arteriosus.
• Thoracoscopic surgery
• Both are safe,0% mortality,100% complete closure.
• Less morbidity with thoracoscopic surgery.
Complications
• Bleeding
• Pneumothorax
• Infection
• Injury to recurrent laryngeal nerve
• Ligation of the left pulmonary artery or aorta
Percutaneous in pre term infants
• 4F catheters,outer diameter <1.3mm.
• Reports of closure in infants <1.5kg.
• Antegrade apporach –femoral vein.
• Late femoral vein thrombosis.
• Device embolization.
Prophylactic closure
• Not advised in preterm infants,even extremely low birth weight ones.
Term infants,children,adults
• 9 months of age – asymptomatic infants.
• Catheter coil/device closure
• Surgery
• Indomethacin – ineffective
Catheter coil/device closure
• Outpatient procedure.
• Sheaths 4-8 Fr.(1.3 to 2.5 mm outer diameter)
• Single coil loop on the pulmonary artery side and the remaining three
to four loops – aortic ductal ampulla.
• Size of the device atleast 2 mm more than the narrow diameter of the
duct.
• >97% success procedural rate.
• >98% closure rate at 6 months.
< 2.5 mm Occluding coils
Platinum, stainless steel
Few mm to < 12 mm ADO,
PFM duct occlud coil
> 12 mm AGA septal occluder,
AGA VSD device,
NMT cardio SEAL device.
Covered stents
Complications
• Embolization
• Usually can be retreived
• Disturbance in the proximal left pulmonary artery or
descending aorta from a protruding device
• Hemolysis from high velocity residual shunting.
• Femoral artery or vein thrombosis
• Infection.
Surgery
• Surgical ligation --- left 4th ICS lateral thoracotomy
• Surgical division
• Midline thoracotomy with cardiopulmonary bypass – complex
cases
• Post device embolization
• Calcified PDA
• VATS
• Transaxillary muscle sparing thoracotomy
Surgery
• Indications : PDA too large for catheter closure.
• Minimal mortlaity and morbidity.
• Return to activity in <3 weeks.
• Video Assisted Thoracoscopic Surgical (VATS) closure.
• Advantages over conventional
• Tearing and hemorrhage with large PDAs in adults (calcified)
• Higher rate of laryngeal nerve injury
PDA with Pulmonary hypertension
 Response to test occlusion with a balloon catheter,O2,NO.
 Good response – closure advised.
 Device closure > surgical.
 Equivocal response –
 Home oxygen
 Sildenafil
 Bosentan
 Inhaled iloprost
 Repeat catheterization 4-9 months later
 Post procedure – pulmonary vasodilators.
 Only C/I to closure – severe pulmonary hypertension with
irreversible pulmonary vascular disease and baseline right to left
ductal shunting despite maximal medical pulmonary vasodilation.
Take home message
• PDA is congenital malformation with a left to right shunt at
great artery level.
• Clinical implications vary depending on the age,anatomy of the
ductus and the underlying cardiovascular status of the patient.
• Echocardiographic diagnosis is enough in most of the
case,reserving the catheterization in complex cases,Pulmonary
hypertension for feasibility.
• Surgery was definitive treatment for PDA previously.
• Transcatheter replacing the surgery over the past 3 decades in
most of the patients.
• Complications can be avoided by appropriate diagnosis and
management.
Questions asked
• 1.what are the lesions to be suspected along with PDA?
• 2.what are ductal dependent lesions ?
• 3.what will be the gradients between the aorta and pulmonary
artery in restrictive,moderately restrictive,unrestricted PDA?
• 4.what is the importance of the ampulla?
• 5.how you will assess the size of device for PDA?
• 6.describe the procedure of PDA device closure?
• 7.how do you suspect based on the catheter course whether PDA
or AP window?
• 8.significant step up at the great artery level ?
• 9.what is the criteria for adequate response of reversibility?
• 10.what is the use of covered stent in PDA?
• 11.in what cases PDA will be kept patent?
CATH MEET PDA

More Related Content

What's hot

Aortic stenosis - Echocardiography
Aortic stenosis - EchocardiographyAortic stenosis - Echocardiography
Aortic stenosis - EchocardiographyAnkur Gupta
 
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONPraveen Nagula
 
Echo in restrictive cardiomyopathy
Echo in restrictive cardiomyopathyEcho in restrictive cardiomyopathy
Echo in restrictive cardiomyopathysruthiMeenaxshiSR
 
Coronary lesion assessment
Coronary lesion assessmentCoronary lesion assessment
Coronary lesion assessmentUday Prashant
 
Echo assessment of aortic stenosis
Echo assessment of aortic stenosisEcho assessment of aortic stenosis
Echo assessment of aortic stenosisNizam Uddin
 
Percutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve InterventionsPercutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve InterventionsPraveen Nagula
 
Contrast Echocardiography
Contrast EchocardiographyContrast Echocardiography
Contrast EchocardiographyAdhi Arya
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionJunhao Koh
 
Shunt Detection And Quantification
Shunt Detection And QuantificationShunt Detection And Quantification
Shunt Detection And QuantificationDang Thanh Tuan
 
Asd echo assessment
Asd echo assessmentAsd echo assessment
Asd echo assessmentMashiul Alam
 
Echo in hypertrophic obstructive cardiomyopathies
Echo in hypertrophic obstructive cardiomyopathiesEcho in hypertrophic obstructive cardiomyopathies
Echo in hypertrophic obstructive cardiomyopathiessruthiMeenaxshiSR
 
BMV balloons- FINAL.pptx
BMV balloons- FINAL.pptxBMV balloons- FINAL.pptx
BMV balloons- FINAL.pptxRohitWalse2
 
ECG interpretation postCRT
ECG interpretation postCRT ECG interpretation postCRT
ECG interpretation postCRT saritadmcardio
 
Transesophageal echocardiography
Transesophageal echocardiographyTransesophageal echocardiography
Transesophageal echocardiographyAmit Gulati
 

What's hot (20)

Aortic stenosis - Echocardiography
Aortic stenosis - EchocardiographyAortic stenosis - Echocardiography
Aortic stenosis - Echocardiography
 
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
 
Echo in restrictive cardiomyopathy
Echo in restrictive cardiomyopathyEcho in restrictive cardiomyopathy
Echo in restrictive cardiomyopathy
 
Coronary lesion assessment
Coronary lesion assessmentCoronary lesion assessment
Coronary lesion assessment
 
Echo assessment of aortic stenosis
Echo assessment of aortic stenosisEcho assessment of aortic stenosis
Echo assessment of aortic stenosis
 
Percutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve InterventionsPercutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve Interventions
 
Contrast Echocardiography
Contrast EchocardiographyContrast Echocardiography
Contrast Echocardiography
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic Function
 
Shunt Detection And Quantification
Shunt Detection And QuantificationShunt Detection And Quantification
Shunt Detection And Quantification
 
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
 
Asd ppt
Asd pptAsd ppt
Asd ppt
 
SEGMENTAL ANALYSIS OF CONGENITAL HEART DISEASE
SEGMENTAL ANALYSIS OF CONGENITAL HEART DISEASE SEGMENTAL ANALYSIS OF CONGENITAL HEART DISEASE
SEGMENTAL ANALYSIS OF CONGENITAL HEART DISEASE
 
Asd echo assessment
Asd echo assessmentAsd echo assessment
Asd echo assessment
 
Echo in hypertrophic obstructive cardiomyopathies
Echo in hypertrophic obstructive cardiomyopathiesEcho in hypertrophic obstructive cardiomyopathies
Echo in hypertrophic obstructive cardiomyopathies
 
TEE VIEWS
TEE VIEWSTEE VIEWS
TEE VIEWS
 
BMV balloons- FINAL.pptx
BMV balloons- FINAL.pptxBMV balloons- FINAL.pptx
BMV balloons- FINAL.pptx
 
Echocardiography in mitral stenosis
Echocardiography in mitral stenosisEchocardiography in mitral stenosis
Echocardiography in mitral stenosis
 
Echocardiography of CHD in Adults
Echocardiography of CHD in AdultsEchocardiography of CHD in Adults
Echocardiography of CHD in Adults
 
ECG interpretation postCRT
ECG interpretation postCRT ECG interpretation postCRT
ECG interpretation postCRT
 
Transesophageal echocardiography
Transesophageal echocardiographyTransesophageal echocardiography
Transesophageal echocardiography
 

Viewers also liked (17)

Coronary Spasm
Coronary SpasmCoronary Spasm
Coronary Spasm
 
Rheumatic heart disease oleh dr robert
Rheumatic heart disease oleh dr robertRheumatic heart disease oleh dr robert
Rheumatic heart disease oleh dr robert
 
Noac
NoacNoac
Noac
 
ECG CHALLENGE
ECG CHALLENGEECG CHALLENGE
ECG CHALLENGE
 
ECG Quiz
ECG QuizECG Quiz
ECG Quiz
 
Land mark trials 2015
Land mark trials 2015Land mark trials 2015
Land mark trials 2015
 
LANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADLANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CAD
 
Coronary Aneurysms
Coronary AneurysmsCoronary Aneurysms
Coronary Aneurysms
 
Cloacal malformation.full
Cloacal malformation.fullCloacal malformation.full
Cloacal malformation.full
 
ECG: Quiz
ECG: QuizECG: Quiz
ECG: Quiz
 
ACUTE RHEUMATIC FEVER IN INDIA
ACUTE RHEUMATIC FEVER IN INDIAACUTE RHEUMATIC FEVER IN INDIA
ACUTE RHEUMATIC FEVER IN INDIA
 
Ecg quiz
Ecg quizEcg quiz
Ecg quiz
 
Advances in Medical Management of Heart Failure
Advances in Medical Management of Heart FailureAdvances in Medical Management of Heart Failure
Advances in Medical Management of Heart Failure
 
Noacs
NoacsNoacs
Noacs
 
Patent ductus arteriosus
Patent ductus arteriosusPatent ductus arteriosus
Patent ductus arteriosus
 
New oral anticoagulants (NOAC) WATAG guidelines
New oral anticoagulants (NOAC) WATAG guidelinesNew oral anticoagulants (NOAC) WATAG guidelines
New oral anticoagulants (NOAC) WATAG guidelines
 
ARM
ARMARM
ARM
 

Similar to CATH MEET PDA

Ccpa catheter basics07medicine
Ccpa catheter basics07medicineCcpa catheter basics07medicine
Ccpa catheter basics07medicineanjika
 
surgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart diseasesurgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart diseasedibufolio
 
Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibilityGOPAL GHOSH
 
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...YolaNewary1
 
REVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORINGREVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORINGGhaleb Almekhlafi
 
ASD ECHO ASSESSMENT renewed slideshow.pptx
ASD ECHO ASSESSMENT renewed slideshow.pptxASD ECHO ASSESSMENT renewed slideshow.pptx
ASD ECHO ASSESSMENT renewed slideshow.pptxAadhi55
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertensionkirti jangra
 
Hypoplastic Left heart dr Alister 3.pptx
Hypoplastic Left heart dr Alister 3.pptxHypoplastic Left heart dr Alister 3.pptx
Hypoplastic Left heart dr Alister 3.pptxGarvAmeta1
 
Patent Ductus Arteriosus: Clinical manifestation and Diagnosis
Patent Ductus Arteriosus: Clinical manifestation and DiagnosisPatent Ductus Arteriosus: Clinical manifestation and Diagnosis
Patent Ductus Arteriosus: Clinical manifestation and DiagnosisNinia Kabir
 
Eisenmenger Syndrome
Eisenmenger SyndromeEisenmenger Syndrome
Eisenmenger SyndromeNishant Tyagi
 
Pulmonary artery-catheter2
Pulmonary artery-catheter2Pulmonary artery-catheter2
Pulmonary artery-catheter2Inba Aras
 
Hemodynamics Basic Concepts
Hemodynamics Basic ConceptsHemodynamics Basic Concepts
Hemodynamics Basic Conceptsvclavir
 
pulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICUpulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICUNeeraj Aggarwal
 
Swan-Ganz-catheterisation_amit-panjwani.pdf
Swan-Ganz-catheterisation_amit-panjwani.pdfSwan-Ganz-catheterisation_amit-panjwani.pdf
Swan-Ganz-catheterisation_amit-panjwani.pdframbhoopal1
 

Similar to CATH MEET PDA (20)

Ccpa catheter basics07medicine
Ccpa catheter basics07medicineCcpa catheter basics07medicine
Ccpa catheter basics07medicine
 
surgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart diseasesurgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart disease
 
Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
 
Pulmonary artery Catheter
Pulmonary artery CatheterPulmonary artery Catheter
Pulmonary artery Catheter
 
Right Ventricle Echocardiography
Right Ventricle EchocardiographyRight Ventricle Echocardiography
Right Ventricle Echocardiography
 
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
 
REVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORINGREVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORING
 
ASD ECHO ASSESSMENT renewed slideshow.pptx
ASD ECHO ASSESSMENT renewed slideshow.pptxASD ECHO ASSESSMENT renewed slideshow.pptx
ASD ECHO ASSESSMENT renewed slideshow.pptx
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Pah seminar kirti
Pah seminar kirtiPah seminar kirti
Pah seminar kirti
 
Hypoplastic Left heart dr Alister 3.pptx
Hypoplastic Left heart dr Alister 3.pptxHypoplastic Left heart dr Alister 3.pptx
Hypoplastic Left heart dr Alister 3.pptx
 
Patent Ductus Arteriosus: Clinical manifestation and Diagnosis
Patent Ductus Arteriosus: Clinical manifestation and DiagnosisPatent Ductus Arteriosus: Clinical manifestation and Diagnosis
Patent Ductus Arteriosus: Clinical manifestation and Diagnosis
 
Eisenmenger Syndrome
Eisenmenger SyndromeEisenmenger Syndrome
Eisenmenger Syndrome
 
Pulmonary artery-catheter2
Pulmonary artery-catheter2Pulmonary artery-catheter2
Pulmonary artery-catheter2
 
Hemodynamics Basic Concepts
Hemodynamics Basic ConceptsHemodynamics Basic Concepts
Hemodynamics Basic Concepts
 
PHT ECHO.pptx
PHT ECHO.pptxPHT ECHO.pptx
PHT ECHO.pptx
 
pulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICUpulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICU
 
Swan-Ganz-catheterisation_amit-panjwani.pdf
Swan-Ganz-catheterisation_amit-panjwani.pdfSwan-Ganz-catheterisation_amit-panjwani.pdf
Swan-Ganz-catheterisation_amit-panjwani.pdf
 
Ppt ph delay
Ppt ph delayPpt ph delay
Ppt ph delay
 
Cyanotic Heart Diseases
Cyanotic Heart DiseasesCyanotic Heart Diseases
Cyanotic Heart Diseases
 

More from Praveen Nagula

historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptxPraveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxPraveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptxPraveen Nagula
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONPraveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxPraveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxPraveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxPraveen Nagula
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not samePraveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIPraveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 

More from Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSION
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 

Recently uploaded

How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 

Recently uploaded (20)

How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 

CATH MEET PDA

  • 2. Case • 2 year old male child. • h/o recurrent LRTIs at presentation. • Patient had h/o breathing difficulty, feeding difficulty and poor weight gain at the age of 3 months. Symptoms decreased with medications,was diagnosed to have a heart disease at this admission. • No H/o cyanotic spells, pedal edema . • No F/o consanguinity, no other member in the family having a Heart disease.
  • 3. On examination: Physical Examination: • weight-8kg, height-81 cm, • No anemia,no cyanosis,no jaundice,no clubbing,no lymphadenopathy,no pedal edema. Vitals : • Pulse - 106/min,regular,high volume & no special character no Radio radial or radiofemoral delay. • B.P-110/50mmhg, • RR-25/min, • Afebrile.
  • 4. CardioVascular System • JVP : normal mean column height with normal wave pattern. Inspection & Palpation : • Apex is in 6th ICS,LV type at Anterior Axillary line, hyperdynamic. • Grade 2/3 parasternal pulsations felt, • Palpable P2, • Systolic thrill in 1st & 2nd Lt ICS. Auscultation: • S1-Normal • S2- Narrow split ; P2 >A2 in Pulmonary Area • no additional sounds • A 4/6 long systolic murmur most prominent in 1st & 2ndLt ICS, high pitched,increases with inspiration, • no other murmur.
  • 5. ECG
  • 6. ECHO • Situs solitus,levocardia, 2atria,2ventricles, AV –VA concordance , NRGA , normal systemic and pulmonary venous drainage. • PDA of size 8mm - shunt is Left to right shunt with Pressure Gradient of 25 mm hg in systole and 10mm in diastole. • PA Systolic pressure of 80 mm hg. • LA, LV are dilated . • Mild MR,no PR,TR. • Normal biventricular function • No associated VSD,COA, ASD. • Left sided aortic arch.
  • 7.  2 year old,Height - 81 cm, weight - 8.5 kg, BMI- 12.95 Kg/m²,  Hb-10.1gm/dl, O2 con-175 ml/min/mt², BSA- 0.48 m²  Catheter course: RT FV---IVC---RA--- RV--- PA---PCW RT FA---Ao---LV PDA ---DES.AORTA. CATHETERISATION PRESSURE DATA in mm Hg FA--- 110/50 (67) RA--- 4 RV--- 80/0-6 PA--- 80/40(54) PCWP--- 5 LV--- 106/0-8 SATURATION DATA in % SVC--- 64.6 IVC--- 68.6 MVO2--- 65.07 RA--- 63.4 RV--- 67.5 PA--- 83.4 FA--- 94.9 PV - 98.0
  • 8. • Qp = 175/13.6 × 10.1×(0.98 -0.83) = 8.73 L/min. • Qs = 175/13.6 × 10.1 ×(0.95 -0.67) = 4.77 L/min. • Qp/Qs = 8.73/4.77 = 1.83 • PVR = 54-5 / 8.73 = 5.612 wood units • SVR = 67-4 / 4.77 = 13.2 wood units • PVRI/SVRI = 5.612/13.2 = 0.425 CATHETERISATION
  • 9. CATHETERISATION POST O2 Pressure Data in mm Hg FA--- 120/74 (90) RA--- 3 RV--- 70/0-4 PA--- 70/40(50) PCWP--- 15 LV--- 115/0-6 Saturation data in % SVC--- 82.1 IVC--- 87.5 MVO2--- 83.45 PA--- 98.7 (pO2=161mmhg) FA--- 99.9 (pO2 =417mmhg)
  • 10. • Qp = 175/(13.6×10.1×0.99+13.34) – (13.6×10.1×0.987 + 5.15) = 17.78L/min. • Qs = 175/(13.6 ×10.1×0.99+13.34)-(13.6×10.1×0.834+1.8) = 6.04L/min. • Qp/Qs= 17.78/6.04 = 2.94 • PVR= 50-15/17.78 = 1.96 wood unit • SVR= 90-3= 14.40 wood unit • PVRI/SVRI =1.96/14.40 = 0.136 CATHETERISATION POST O2
  • 11. Case 2 • 3 yr old F • Wt 13.6 kgs • Child had been very active,without evident dyspnea or cyanosis. • A murmur was first reported at 1 ½ yrs. • Her development was normal for her age. • Mild pallor • JVP normal,BP – 104/38mmHg • Systolic at left 2nd and 3rd Left ICS. • P2 masked by murmurs. • Very loud,continuous,machinery type systolic and diastolic murmurs,left 2nd 3rd ICS. • ECG- normal ,normal axis,LVH
  • 12. Cath data Pressure data (mm Hg) • RA – 5 • RV – 31/4 (13) • PA – 30/13(19) • LA – 8 • LV – 90/40 (65) Saturation data • IVC – 65 • SVC – 62 • MV02 – 62.75 • RA – 61 • RV - 65 • MPA – 65 • LPA – 80 • AORTA – 95 PDA without pulmonary hypertension Qs – 2.38 l/min Qp – 4.98 l min Qp/Qs – 2.09:1
  • 13. Case3 • 8yrs old F • Weight 18.4 kg • 2 episodes of pneumonia and frequent bronchitis. • Less active than other children.easy fatiguability and dyspnea on climbing more than one flight of stairs. • No h/o suggestive of rheumatic fever. • Fragile,under developed child. • No cyanosis. • Examination: slight precordial bulge to left of sternum. • JVP normal • Systolic thrill at left 2nd ICS. • S1 loud,P2 accentuated. • Long loud coarse systolic • Coarse early to mid diastolic left 2nd ICS. • High pitch Systolic murmur LLSB. • MDM at apex • ECG- notching of P wave,biventricular hypertrophy
  • 14. Cath data • Saturation data: • SVC – 60 • IVC – 65 • MVO2 – 61.25 • RA – 60 • RV – 72 • PA – 88 • PV - 98 • Aorta -98 Pressure data: RA – 5 RV - 64/6(25) PA – 64/23(39) LV – 104/10 Aorta – 107/46(73) LA – 8 Qp = 9.50 lit/min Qs = 3.10 lit/min L-R shunt ventricular – 0.90 lit/min Aorta to pulmonary – 5.5 lit/min PDA with VSD with pulmonary hypertension
  • 16. Indications for catheterization • Usually does not require. • Color doppler is as sensitive as cardiac catheterization for detecting even a small PDA. • 1.Clinical findings – symptomatology discreprancy. • 2.Severity of pulmonary hypertension. • 3.Reactivity to pulmonary vasodilators. • 4.If closure is indicated in a particular case scenario. • 5.Detection of assosciated lesions.
  • 17. • Right heart catheterization – suffices to confirm diagnosis. • Venous catheter from MPA – PDA – descending aorta. • Retrograde – if interatrial spetum is intact, LV cannot be entered prograde. • Catheters used. • Multipurpose catheter • Pigtail
  • 18. Angiographic views • Defining the anatomy of the PDA. • Left Lateral projection. – for sizing of device • LAO 60 - profile of PDA • RAO caudal • RAO 30 – ampulla at pulmonary end
  • 19. Isolated PDA type A DuctusinTricuspidatresia Ductusarisingmoreproximally Ductusarisingmoreproximally,elongated Ductusarisingveryproximallyundersideofarchtypicallyseenin TOF-PA DuctusarisingfromsubclavianarteryinTOFPAwithrightsided aorticarch
  • 20. Significant shunt at great arteries • An increase of pulmonary arterial blood oxygen content of >0.5mL/dL or a saturation increase of >4% to 5% from that in right ventricular blood indicates a significant left to right shunt at the pulmonary arterial level.
  • 21. Imp points Feature Implication Increase in O2 saturation just below the pulmonary valve Pulmonary Regurgiation A sample from either one of the pulmonary artery branches does not reflect mixed pulmonary arterial blood oxygen saturation preferential streaming of oxygenated blood from the PDA into one or another pulmonary branch. Accurate pulmonary blood flow from blood oxygen data difficult Accurate calculation of true magnitude of left to right shunting impossible Reduced PVO2 LV failure with pulmonary edema Increased O2 saturation in RA blood PFO with L-R shunt Presence of large ASD Masks the significant shunt at great artery level O2 saturation of blood in the descending aorta less than that obtained in the ascending aorta Significant Pulmonary hypertension,R-L shunting
  • 22. • Increase in oxygen saturation in pulmonary arterial blood is not diagnostic of a PDA, But may be present in lesions such as • Aortopulmonary window, • Supracristal VSD,  streaming may direct the highly saturated blood into the pulmonary artery. • Calculation of pulmonary blood flow is inaccurate,the calculation of pulmonary vascular resistance is also inaccurate.
  • 23. Shunt depends upon 3 major factors • Diameter and the length of the ductus arteriosus • Pressures between the aorta and the pulmonary artery • Systemic and pulmonary vascular resistances
  • 24. Pulmonary arterial blood pressure Systemic arterial pressures Pulse pressure SBP/DBP/MP SBP/DBP/MP Small PDA normal Low diastolic pressure widened Moderate sized PDA Slightly elevated,less than Systemic Pressures Low DBP Mean pressure elevated widened Large PDA with pulmonary hypertension Equal to Systemic pressures Increased LVEDP Diastolic gradient between LA and LV LA mean pressure may be increased Prominent V wave Small systolic difference between LV and aorta decreased
  • 25. Classifications • Krichenko’s classification • Sri Chitra Tirunal classification • Size of the ductus • Staging of PDA
  • 26. Krichenko classification Type A : CONICAL ductus Well defined aortic ampulla Constriction near pulmonary artery end Type B : WINDOW ductus Very short length Type C : TUBULAR ductus No constrictions Type D: COMPLEX ductus multiple constrictions Type E: ELONGATED ductus Constriction remote from the anterior edge of trachea
  • 27. Krichenko et al .Am J Cardiol.1989;63:877-79
  • 28. Sri Chitra Tirunal Classification of PDA, ProfJaganMohanA.Tharakanetal.(2003) • Angiographic appearance of PDA • Retrograde analysis of the appearance of PDA on angiography selected for device closure. Magnification factor = catheter size measured on the screen / Actual catheter size. • Measurement of anatomical components of ductus Ex: Ampulla size = ampulla measured on screen / magnification factor. Lateral view 167 pts
  • 29. Patentductusarteriosus Saucer shaped Length of the ductus < 6 mm Narrowing at PA end by > 50% of the width of the ampulla Cylindrical (tubular ductus) Length of ductus > 6mm Narrowing at PA end by < 50 % the width of ampulla Conical (cup shaped) Length of ductus > 6mm Narrowing at PA end >50% of the width of ampulla Length of this narrow portion (stem of the ductus ) < 1/3 of the total length of the ductus Funnel shaped Similar to conical Longer stem >1/3 of the total length of ductus Hour glass shaped Ampulla at both PA end and the aortic end
  • 30. Patent Ductus Arteriosus Length of ductus < 6mm PA end narrowing > 50% of width of ampulla Saucer shaped > 6mm PA end narrowing > 50% width of ampulla Length of narrow portion < 1/3 of length of ductus Conical (cup shaped) Longer stem Funnel shaped < 50 % of width of ampulla Cylindrical Ampulla Usually at aortic end At both ends Hourglass type
  • 31. Saucer shaped ductus Shallow depth of ductus Hardly any narrowing at the pulmonary end
  • 32.
  • 33. Based on size of ductus
  • 34. Staging of PDA • Clinical • C1 – Asymptomatic • C2 – Mild • C3 – Moderate • C4 – severe • Echocardiography • E1 – no evidence of flow on 2D or doppler interrogation • E2 - small non significant ductus • E3 – moderate HSDA • E4 - Large HSDA
  • 36. Treatment of preterm infantsMedical : Oral /IV indomethacin • Effects are apparent when administered < 10 days of age, less mature infants. • Infants <1000g before manifestation (<72 hrs of age). • C/I : Renal dysfunction, necrotizing enterocolitis,overt bleeding, shock, ECG evidence of myocardial ischemia. • Serum creatinine >1.6mg/dl, BUN >20 mg/dl. • Dose – 0.2mg/kg NG or IV. • A total of three doses,12-24 hrs apart, based on urinary output. • If urine flow decreases – increase the time period or less doses. • Second course if clinical signs reappear. • True prophylactic therapy on the first day after birth - no advantage. • Refractory patients – L NMMA and indomethacin. Ibuprofen (less side effects,increased pulmonary hypertension). Oral paracetamol < 48 hrs Subsequent two doses are 0.10mg/kg IV 2-7 days 0.20mg/kg >7 days 0.25mg/kg
  • 37. Surgical • Unsuccessful /not possible medical treatment. • <10 days of age -  duration of ventilatory support,hospital stay,lowers morbidity. • Ligation rather than division of ductus arteriosus. • Thoracoscopic surgery • Both are safe,0% mortality,100% complete closure. • Less morbidity with thoracoscopic surgery.
  • 38. Complications • Bleeding • Pneumothorax • Infection • Injury to recurrent laryngeal nerve • Ligation of the left pulmonary artery or aorta
  • 39. Percutaneous in pre term infants • 4F catheters,outer diameter <1.3mm. • Reports of closure in infants <1.5kg. • Antegrade apporach –femoral vein. • Late femoral vein thrombosis. • Device embolization.
  • 40. Prophylactic closure • Not advised in preterm infants,even extremely low birth weight ones.
  • 41. Term infants,children,adults • 9 months of age – asymptomatic infants. • Catheter coil/device closure • Surgery • Indomethacin – ineffective
  • 42. Catheter coil/device closure • Outpatient procedure. • Sheaths 4-8 Fr.(1.3 to 2.5 mm outer diameter) • Single coil loop on the pulmonary artery side and the remaining three to four loops – aortic ductal ampulla. • Size of the device atleast 2 mm more than the narrow diameter of the duct. • >97% success procedural rate. • >98% closure rate at 6 months. < 2.5 mm Occluding coils Platinum, stainless steel Few mm to < 12 mm ADO, PFM duct occlud coil > 12 mm AGA septal occluder, AGA VSD device, NMT cardio SEAL device. Covered stents
  • 43.
  • 44. Complications • Embolization • Usually can be retreived • Disturbance in the proximal left pulmonary artery or descending aorta from a protruding device • Hemolysis from high velocity residual shunting. • Femoral artery or vein thrombosis • Infection.
  • 45. Surgery • Surgical ligation --- left 4th ICS lateral thoracotomy • Surgical division • Midline thoracotomy with cardiopulmonary bypass – complex cases • Post device embolization • Calcified PDA • VATS • Transaxillary muscle sparing thoracotomy
  • 46. Surgery • Indications : PDA too large for catheter closure. • Minimal mortlaity and morbidity. • Return to activity in <3 weeks. • Video Assisted Thoracoscopic Surgical (VATS) closure. • Advantages over conventional • Tearing and hemorrhage with large PDAs in adults (calcified) • Higher rate of laryngeal nerve injury
  • 47. PDA with Pulmonary hypertension  Response to test occlusion with a balloon catheter,O2,NO.  Good response – closure advised.  Device closure > surgical.  Equivocal response –  Home oxygen  Sildenafil  Bosentan  Inhaled iloprost  Repeat catheterization 4-9 months later  Post procedure – pulmonary vasodilators.  Only C/I to closure – severe pulmonary hypertension with irreversible pulmonary vascular disease and baseline right to left ductal shunting despite maximal medical pulmonary vasodilation.
  • 48. Take home message • PDA is congenital malformation with a left to right shunt at great artery level. • Clinical implications vary depending on the age,anatomy of the ductus and the underlying cardiovascular status of the patient. • Echocardiographic diagnosis is enough in most of the case,reserving the catheterization in complex cases,Pulmonary hypertension for feasibility. • Surgery was definitive treatment for PDA previously. • Transcatheter replacing the surgery over the past 3 decades in most of the patients. • Complications can be avoided by appropriate diagnosis and management.
  • 49. Questions asked • 1.what are the lesions to be suspected along with PDA? • 2.what are ductal dependent lesions ? • 3.what will be the gradients between the aorta and pulmonary artery in restrictive,moderately restrictive,unrestricted PDA? • 4.what is the importance of the ampulla? • 5.how you will assess the size of device for PDA? • 6.describe the procedure of PDA device closure? • 7.how do you suspect based on the catheter course whether PDA or AP window? • 8.significant step up at the great artery level ? • 9.what is the criteria for adequate response of reversibility? • 10.what is the use of covered stent in PDA? • 11.in what cases PDA will be kept patent?